124 related articles for article (PubMed ID: 23859903)
1. Health technology assessment of computer-assisted pap test screening in Italy.
Dalla Palma P; Moresco L; Giorgi Rossi P;
Acta Cytol; 2013; 57(4):349-58. PubMed ID: 23859903
[TBL] [Abstract][Full Text] [Related]
2. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
Della Palma P; Moresco L; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
[TBL] [Abstract][Full Text] [Related]
3. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
[TBL] [Abstract][Full Text] [Related]
4. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
5. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
Tay SK; Lin LE; Goh RC
Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
[TBL] [Abstract][Full Text] [Related]
6. Liquid-based cytology: evaluation of effectiveness, cost-effectiveness, and application to present practice.
Cox JT
J Natl Compr Canc Netw; 2004 Nov; 2(6):597-611. PubMed ID: 19780303
[TBL] [Abstract][Full Text] [Related]
7. Comparison of ThinPrep Integrated Imager-Assisted Screening versus Manual Screening of ThinPrep Liquid-Based Cytology Specimens.
Tanaka K; Aoki D; Tozawa-Ono A; Suzuki N; Takamatsu K; Nakamura M; Tsunoda H; Seino S; Kobayashi N; Shirayama T; Takahashi F
Acta Cytol; 2020; 64(5):486-491. PubMed ID: 32535593
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of liquid-based cytology with or without hybrid-capture II HPV test compared with conventional Pap smears: a study by the French Society of Clinical Cytology.
Cochand-Priollet B; Cartier I; de Cremoux P; Le Galès C; Ziol M; Molinié V; Petitjean A; Dosda A; Merea E; Biaggi A; Gouget I; Arkwright S; Vacher-Lavenu MC; Vielh P; Coste J
Diagn Cytopathol; 2005 Nov; 33(5):338-43. PubMed ID: 16240398
[TBL] [Abstract][Full Text] [Related]
9. Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.
Bowditch RC; Clarke JM; Baird PJ; Greenberg ML
Diagn Cytopathol; 2015 Nov; 43(11):870-8. PubMed ID: 26174002
[TBL] [Abstract][Full Text] [Related]
10. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico.
Flores YN; Bishai DM; Lorincz A; Shah KV; Lazcano-Ponce E; Hernández M; Granados-García V; Pérez R; Salmerón J
Cancer Causes Control; 2011 Feb; 22(2):261-72. PubMed ID: 21170578
[TBL] [Abstract][Full Text] [Related]
11. Implementation of the ThinPrep Imaging System in a tertiary military medical center.
Duby JM; DiFurio MJ
Cancer; 2009 Aug; 117(4):264-70. PubMed ID: 19536887
[TBL] [Abstract][Full Text] [Related]
12. A retrospective validation of the FocalPoint GS slide profiler NFR technology by analysis of interval disease outcomes compared with manual cytology.
Nuttall DS; Hillier S; Clayton HR; Savage AJ; Martin CM; O'Leary JJ
Cancer Cytopathol; 2019 Apr; 127(4):240-246. PubMed ID: 30825407
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of 21 alternative cervical cancer screening strategies.
Chuck A
Value Health; 2010; 13(2):169-79. PubMed ID: 19804436
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CellSolutions BestPrep® automated thin-layer liquid-based cytology Papanicolaou slide preparation and BestCyte® cell sorter imaging system.
Delga A; Goffin F; Kridelka F; Marée R; Lambert C; Delvenne P
Acta Cytol; 2014; 58(5):469-77. PubMed ID: 25277345
[TBL] [Abstract][Full Text] [Related]
15. A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol.
Kitchener HC; Gittins M; Desai M; Smith JH; Cook G; Roberts C; Turnbull L
Health Technol Assess; 2015 Mar; 19(22):i-xix, 1-64. PubMed ID: 25774649
[TBL] [Abstract][Full Text] [Related]
16. Implementation of the ThinPrep imaging system in a high-volume metropolitan laboratory.
Miller FS; Nagel LE; Kenny-Moynihan MB
Diagn Cytopathol; 2007 Apr; 35(4):213-7. PubMed ID: 17351933
[TBL] [Abstract][Full Text] [Related]
17. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
Karnon J; Peters J; Platt J; Chilcott J; McGoogan E; Brewer N
Health Technol Assess; 2004 May; 8(20):iii, 1-78. PubMed ID: 15147611
[TBL] [Abstract][Full Text] [Related]
18. Cytology versus HPV testing for cervical cancer screening in the general population.
Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
[TBL] [Abstract][Full Text] [Related]
19. The ThinPrep Pap test. A review of clinical studies.
Linder J; Zahniser D
Acta Cytol; 1997; 41(1):30-8. PubMed ID: 9022723
[TBL] [Abstract][Full Text] [Related]
20. Prospective parallel randomized trial of the MultiCyte™ ThinPrep(®) imaging system: the Scottish experience.
Palmer TJ; Nicoll SM; McKean ME; Park AJ; Bishop D; Baker L; Imrie JE
Cytopathology; 2013 Aug; 24(4):235-45. PubMed ID: 22616770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
